Patel, RP, Ghilardi, G, Zhang, Y, Chiang, YH, Xie, W, Guruprasad, P, Kim, KH, Chun, I, Angelos, M, Pajarillo, R, Hong, SJ, Lee, YG, Shestova, O, Shaw, C, Cohen, IJ, Gupta, A, Vu, T, Qian, D, Yang, S, Nimmagadda, A, Snook, AE, Siciliano, N, Rotolo, A, Inamdar, A, Harris, J, Ugwuanyi, O, Wang, L , Carturan, A, Paruzzo, L, Chen, L, Ballard, HJ, Blanchard, T, Xu, C, Abdel-Mohsen, M, Gabunia, K, Wysocka, M, Linette, GP, Carreno, BM, Barrett, DM, Teachey, DT, Posey, AD, Powell, D, Sauter, CT, Pileri, S, Pillai, V, Scholler, J, Rook, AH, Schuster, SJ, Barta, S, Porazzi, P, Ruella, M
Nanoceria-mediated cyclosporin a delivery for dry eye disease management through modulating immuneepithelial crosstalk
81 In addition to H
M Sharma J Burre 2023 Alpha-Synuclein in synaptic function and dysfunction Trends Neurosci 46 2 153 166 MG Spillantini M Goedert 2016 Synucleinopathies: past, present and future Neuropathol Appl Neurobiol DJ Surmeier JA Obeso GM Halliday 2017 Selective neuronal vulnerability in Parkinson disease Nat Rev Neurosci 18 2 101 113 Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S et al (2015) Gut microbiota are related to Parkinsons disease and clinical phenotype
Biodegradation 24(5):615630
10.1371/journal.pone.0060074 5 AhmedS.UllahN.ParveenS.JavedI.JalilN